Use of tocilizumab for severe hantavirus pulmonary syndrome: a MEURI case series with contextual comparisons - The Lancet
Published Jun 16, 2026, 07:00 AM UTC ·
Source: The Lancet
A case series published in The Lancet discusses the use of tocilizumab as a treatment for severe hantavirus pulmonary syndrome, providing contextual comparisons.
Read the full story (original source)
https://news.google.com/rss/articles/CBMiwwFBVV95cUxOUTFZSHljMEZyOHFGR1ZQbi1DdFJCMXNwdkQ2dnc0cGtMTEZGR1B2dHBRYmtQdGtJS3Q0cTlnbTJIUzlfSUJwMDM0Y2c4WXBVbHdEQUxIMVpEZkpTZHhzX2sySmI0ZWNBcnNjM0U2Ui1iMFRCY2g2QXVrOUJTcnBGQUQ0YUFuV1l0TVBHWjBGSGRISUh1eTBkLU9OcDhkWG55SHk1bzktQ0pUYkQyVGZGWjk5dTJhcDZCNTNTZWhyc0ZZRW8?oc=5
⚠ This page summarizes a third-party news report (with translation when the source is not in English). The original is always linked above. Not medical advice.